Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: The unknown risks

Vox Sanguinis

Volumn 105, Issue 4, 2013, Pages 271-282

  Francis, R O ^a   Jhang, J S ^a   Pham, H P ^a   Hod, E A ^a   Zimring, J C ^b   Spitalnik, S L ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

Author keywords

Glucose 6 phosphate dehydrogenase deficiency; Haemolysis; Oxidative stress; Sickle cell disease; Transfusion

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; METHEMOGLOBIN REDUCTASE; PEROXIREDOXIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE;

AMINO ACID SUBSTITUTION; DIABETIC KETOACIDOSIS; DRUG HALF LIFE; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME SUBSTRATE; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; GAMMA IRRADIATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMAN; INTRAVASCULAR HEMOLYSIS; MICHAELIS CONSTANT; NONHUMAN; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; REVIEW; STEADY STATE; THERMOSTABILITY;

GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY; HAEMOLYSIS; OXIDATIVE STRESS; SICKLE-CELL DISEASE; TRANSFUSION;

BLOOD DONORS; ERYTHROCYTE TRANSFUSION; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMANS; MALE; TRANSFUSION MEDICINE;

EID: 84885485985     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12068     Document Type: Review

References (113)

1. Alving AS, Carson PE, Flanagan CL, et al.: Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956; 124:484-485
2. Nkhoma ET, Poole C, Vannappagari V, et al.: The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009; 42:267-278
3. Lachant NA, Noble NA, Myrhe BA, et al.: Antioxidant metabolism during blood storage and its relationship to posttransfusion red cell survival. Am J Hematol 1984; 17:237-249
4. Orlina AR, Josephson AM, McDonald BJ: The poststorage viability of glucose-6-phosphate dehydrogenase-deficient erythrocytes. J Lab Clin Med 1970; 75:930-936
5. Kumar P, Sarkar S, Narang A: Acute intravascular haemolysis following exchange transfusion with G-6-PD deficient blood. Eur J Pediatr 1994; 153:98-99
6. Mimouni F, Shohat S, Reisner SH: G6PD-deficient donor blood as a cause of hemolysis in two preterm infants. Isr J Med Sci 1986; 22:120-122
7. Shalev O, Bogomolski-Yahalom V, Sharon R: Hemolysis following transfusion of erythrocytes from a donor with G6PD deficiency and beta-thalassemia minor. Isr J Med Sci 1993; 29:214-216
8. Shalev O, Manny N, Sharon R: Posttransfusional hemolysis in recipients of glucose-6-phosphate dehydrogenase-deficient erythrocytes. Vox Sang 1993; 64:94-98
9. Van Der Sar A, Schouten H, Boudier AM: Glucose-6-phosphate dehydrogenase deficiency in red cells. Incidence in the Cura Cao Population, Its clinical and genetic aspects. Enzymologia 1964; 27:289-310
10. Francis R, Jhang J, Hendrickson J, et al.: Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service. Transfusion 2013; 53:606-611
11. Wood ZA, Schroder E, Robin Harris J, et al.: Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003; 28:32-40
12. Kirkman HN, Galiano S, Gaetani GF: The function of catalase-bound NADPH. J Biol Chem 1987; 262:660-666
13. Szabo P, Purrello M, Rocchi M, et al.: Cytological mapping of the human glucose-6-phosphate dehydrogenase gene distal to the fragile-X site suggests a high rate of meiotic recombination across this site. Proc Natl Acad Sci USA 1984; 81:7855-7859
14. Naylor CE, Rowland P, Basak AK, et al.: Glucose 6-phosphate dehydrogenase mutations causing enzyme deficiency in a model of the tertiary structure of the human enzyme. Blood 1996; 87:2974-2982
15. Persico MG, Viglietto G, Martini G, et al.: Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region. Nucleic Acids Res 1986; 14:2511-2522
16. Marks PA, Johnson AB, Hirschberg E: Effect of age on the enzyme activity in erythrocytes. Proc Natl Acad Sci USA 1958; 44:529-536
17. Beutler E: A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency. Blood 1966; 28:553-562
18. Brewer GJ, Tarlov AR, Alving AS: The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis. JAMA 1962; 180:386-388
19. Beutler E: The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity. J Lab Clin Med 1957; 49:84-95
20. Farez-Vidal ME, Gandia-Pla S, Blanco S, et al.: Multi-mutational analysis of fifteen common mutations of the glucose 6-phosphate dehydrogenase gene in the Mediterrranean population. Clin Chim Acta 2008; 395:94-98
21. Minucci A, Moradkhani K, Hwang MJ, et al.: Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood Cells Mol Dis 2012; 48:154-165
22. Beutler E, Gaetani G, der Kaloustian V, et al.: Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ 1989; 67:601-611
23. Bernini L, Latte B, Siniscalco M, et al.: Survival of 51 Cr-labelled red cells in subjects with thalassaemia-trait or G6pd deficiency or both abnormalities. Br J Haematol 1964; 10:171-180
24. Ragusa R, Di Cataldo A, Gangarossa S, et al.: Low-grade haemolysis and assessment of iron status during the steady state in G6PD-deficient subjects. Acta Haematol 1993; 90:25-28
25. Brewer GJ, Tarlov AR, Kellermeyer RW: The hemolytic effect of primaquine. XII. Shortened erythrocyte life span in primaquine-sensitive male Negroes in the absence of drug administration. J Lab Clin Med 1961; 58:217-224
26. Dern RJ, Beutler E, Alving AS: The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med 1954; 44:171-176
27. Pannacciulli I, Tizianello A, Ajmar F, et al.: The course of experimentally induced hemolytic anemia in a primaquine-sensitive Caucasian. A case study. Blood 1965; 25:92-95
28. Ruwende C, Khoo SC, Snow RW, et al.: Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376:246-249
29. Clark IA, Hunt NH: Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun 1983; 39:1-6
30. Cappadoro M, Giribaldi G, O'Brien E, et al.: Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998; 92:2527-2534
31. Mason PJ, Bautista JM, Gilsanz F: G6PD deficiency: the genotype-phenotype association. Blood Rev 2007; 21:267-283
32. Heller P, Best WR, Nelson RB, et al.: Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 1979; 300:1001-1005
33. Goldberg B, Stern A: The mechanism of oxidative hemolysis produced by phenylhydrazine. Mol Pharmacol 1977; 13:832-839
34. McMillan DC, Powell CL, Bowman ZS, et al.: Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents. Toxicol Sci 2005; 88:274-283
35. Grossman SJ, Simson J, Jollow DJ: Dapsone-induced hemolytic anemia: effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes. Toxicol Appl Pharmacol 1992; 117:208-217
36. Jollow DJ, McMillan DC: Oxidative stress, glucose-6-phosphate dehydrogenase and the red cell. Adv Exp Med Biol 2001; 500:595-605
37. Raineri R, Levy HR: On the specificity of steroid interaction with mammary glucose 6-phosphate dehydrogenase. Biochemistry 1970; 9:2233-2243
38. Leopold JA, Dam A, Maron BA, et al.: Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 2007; 13:189-197
39. Dechatelet LR, Cooper MR, McCall CE: Dissociation by colchicine of the hexose monophosphate shunt activation from the bactericidal activity of the leukocyte. Infect Immun 1971; 3:66-72
40. Hutton JJ: Genetic regulation of glucose 6-phosphate dehydrogenase activity in the inbred mouse. Biochem Genet 1971; 5:315-331
41. Pretsch W, Charles DJ, Merkle S: X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus. Biochem Genet 1988; 26:89-103
42. Longo L, Vanegas OC, Patel M, et al.: Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J 2002; 21:4229-4239
43. Tizianello A, Pannacciulli I, Ajmar F, et al.: Sites of destruction of red cells in G-6-PD deficient Caucasians and in phenylhydrazine treated patients. Scand J Haematol 1968; 5:116-128
44. Datta K, Soni JL, Awadhiya RP, et al.: Erythrophagocytosis in phenylhydrazine induced acute anaemia in chickens. Res Vet Sci 1989; 47:136-137
45. Horn S, Bashan N, Gopas J: Phagocytosis of phenylhydrazine oxidized and G-6-PD-deficient red blood cells: the role of cell-bound immunoglobulins. Blood 1991; 78:1818-1825
46. Horn S, Gopas J, Bashan N: A lectin-like receptor on murine macrophage is involved in the recognition and phagocytosis of human red cells oxidized by phenylhydrazine. Biochem Pharmacol 1990; 39:775-780
47. Terpstra V, van Berkel TJ: Scavenger receptors on liver kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 2000; 95:2157-2163
48. Fischer TM, Meloni T, Pescarmona GP, et al.: Membrane cross bonding in red cells in favic crisis: a missing link in the mechanism of extravascular haemolysis. Br J Haematol 1985; 59:159-169
49. Beutler E: G6PD deficiency. Blood 1994; 84:3613-3636
50. Youngster I, Arcavi L, Schechmaster R, et al.: Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf 2010; 33:713-726
51. Scott GL, Rasbridge MR: The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells. Br J Haematol 1973; 24:307-317
52. Magon A, Leipzig RM, Bloom K, et al.: Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential. Prog Clin Biol Res 1981; 55:709-724
53. Burka ER, Weaver Z, Marks PA: Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 1966; 64:817-825
54. Raupp P, Hassan JA, Varughese M, et al.: Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency. Arch Dis Child 2001; 85:411-412
55. Senanayake N, Sanmuganathan PS: Acute intravascular haemolysis in glucose-6-phosphate dehydrogenase deficient patients following ingestion of herbal broth containing Acalypha indica. Trop Doct 1996; 26:32
56. Wong HB: Singapore kernicterus. Singapore Med J 1980; 21:556-567
57. Ko CH, Li K, Ng PC, et al.: Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro. Toxicol In Vitro 2008; 22:1222-1227
58. Mehta JB, Singhal SB, Mehta BC: Ascorbic-acid-induced haemolysis in G-6-PD deficiency. Lancet 1990; 336:944
59. Winterbourn CC: Protection by ascorbate against acetylphenylhydrazine-induced Heinz body formation in glucose-6-phosphate dehydrogenase deficient erythrocytes. Br J Haematol 1979; 41:245-252
60. Udomratn T, Steinberg MH, Campbell GD Jr, et al.: Effects of ascorbic acid on glucose-6-phosphate dehydrogenase-deficient erythrocytes: studies in an animal model. Blood 1977; 49:471-475
61. Levine M, Padayatty SJ, Espey MG: Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr 2011; 2:78-88
62. Agarwal RK, Moudgil A, Kishore K, et al.: Acute viral hepatitis, intravascular haemolysis, severe hyperbilirubinaemia and renal failure in glucose-6-phosphate dehydrogenase deficient patients. Postgrad Med J 1985; 61:971-975
63. Au WY, Chan SC: Association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and fatal outcome of hepatitis E infection in middle-aged men. Singapore Med J 2012; 53:148-149
64. Pitcher CS, Williams R: Reduced red cell survival in jaundice and its relation to abnormal glutathione metabolism. Clin Sci 1963; 24:239-252
65. Kasper ML, Miller WJ, Jacob HS: G6PD-deficiency infectious haemolysis: a complement dependent innocent bystander phenomenon. Br J Haematol 1986; 63:85-91
66. Spolarics Z, Condon MR, Siddiqi M, et al.: Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice. Am J Physiol Heart Circ Physiol 2004; 286:H2118-H2126
67. Illing EK, Gray CH, Lawrence RD: Blood glutathione and non-glucose reducing substances in diabetes. Biochem J 1951; 48:637-640
68. Shalev O, Wollner A, Menczel J: Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Br Med J 1984; 288:179-180
69. Vanelli M, Lucentini L, Picco P, et al.: Blood glucose normalization-induced haemolysis in three adolescents with type 1 diabetes mellitus at onset and unknown G-6-PD deficiency. J Pediatr Endocrinol Metab 1996; 9:193-196
70. Shalev O, Eliakim R, Lugassy GZ, et al.: Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency. Acta Haematol 1985; 74:227-229
71. Pilo F, Baronciani D, Depau C, et al.: Safety of hematopoietic stem cell donation in glucose 6 phosphate dehydrogenase-deficient donors. Bone Marrow Transplant 2013; 48:36-39
72. Au WY, Lie AK, Lam KY, et al.: Engraftment of umbilical cord blood with glucose 6-phosphate dehydrogenase deficiency after double-unit unrelated cord blood transplantation. Bone Marrow Transplant 2009; 44:57-58
73. Au WY, Ma SK, Lie AK, et al.: Glucose-6-phosphate dehydrogenase deficiency and hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29:399-402
74. Au WY, Pang A, Lam KK, et al.: G6PD deficiency from lyonization after hematopoietic stem cell transplantation from female heterozygous donors. Bone Marrow Transplant 2007; 40:677-681
75. Bennett-Guerrero E, Veldman TH, Doctor A, et al.: Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007; 104:17063-17068
76. Rubin O, Crettaz D, Canellini G, et al.: Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008; 95:288-297
77. D'Alessandro A, D'Amici GM, Vaglio S, et al.: Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics. Haematologica 2012; 97:107-115
78. Korgun DK, Bilmen S, Yesilkaya A: Alterations in the erythrocyte antioxidant system of blood stored in blood bags. Res Commun Mol Pathol Pharmacol 2001; 109:357-363
79. Rael LT, Bar-Or R, Ambruso DR, et al.: The effect of storage on the accumulation of oxidative biomarkers in donated packed red blood cells. J Trauma 2009; 66:76-81
80. Wagner GM, Chiu DT, Qju JH, et al.: Spectrin oxidation correlates with membrane vesiculation in stored RBCs. Blood 1987; 69:1777-1781
81. Dumont LJ, Yoshida T, AuBuchon JP: Anaerobic storage of red blood cells in a novel additive solution improves in vivo recovery. Transfusion 2009; 49:458-464
82. D'Amici GM, Rinalducci S, Zolla L: Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res 2007; 6:3242-3255
83. Racek J, Herynkova R, Holecek V, et al.: Influence of antioxidants on the quality of stored blood. Vox Sang 1997; 72:16-19
84. Arun P, Padmakumaran NK, Manojkumar V, et al.: Decreased hemolysis and lipid peroxidation in blood during storage in the presence of nicotinic acid. Vox Sang 1999; 76:220-225
85. Rocchigiani M, Pescaglini M, Sestini S, et al.: Density increase and ageing of erythrocytes in stored blood. J Int Med Res 1989; 17:461-466
86. Agarwal P, Ray VL, Choudhury N, et al.: Effect of gamma irradiation on blood from glucose 6 phosphate dehydrogenase deficient blood donors. Hematology 2007; 12:267-270
87. Westerman MP, Wald N, Diloy-Puray M: Irradiation shortens the survival time of red cells deficient in glucose-6-phosphate dehydrogenase. Radiat Res 1980; 81:473-477
88. Dern RJ, Gwinn RP, Wiorkowski JJ: Studies on the preservation of human blood. I. Variability in erythrocyte storage characteristics among healthy donors. J Lab Clin Med 1966; 67:955-965
89. Samanta S, Kumar P, Kishore SS, et al.: Donor blood glucose 6-phosphate dehydrogenase deficiency reduces the efficacy of exchange transfusion in neonatal hyperbilirubinemia. Pediatrics 2009; 123:e96-e100
90. Huang CS, Sung YC, Huang MJ, et al.: Content of reduced glutathione and consequences in recipients of glucose-6-phosphate dehydrogenase deficient red blood cells. Am J Hematol 1998; 57:187-192
91. McCurdy PR, Morse EE: Glucose-6-phosphate dehydrogenase deficiency and blood transfusion. Vox Sang 1975; 28:230-237
92. Rother RP, Bell L, Hillmen P, et al.: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293:1653-1662
93. Akanni EOOBSA, Agbona VO, Tijani BA, et al.: Glucose-6-phosphate dehydrogenase deficiency in blood donors and jaundiced neonates in Osogbo, Nigeria. J Med Lab Diagn 2010; 1:1-4
94. Garlick M: Glucose-6-phosphate dehydrogenase deficiency in blood donors. Can J Med Technol 1969; 31:125-130
95. Kuhn VL, Lisboa V, de Cerqueira LP: Glucose-6-phosphate dehydrogenase deficiency in blood donors in a general hospital of Salvador, Bahia, Brazil. Rev Paul Med 1983; 101:175-177
96. Casado A, Casado MC, Lopez-Fernandez ME, et al.: Thalassemia and G6PD deficiency in Spanish blood donors. Panminerva Med 1997; 39:205-207
97. Emamghorashi F, Hoshmand F, Mohtashamifar A: Screening for glucose-6-phosphate dehydrogenase deficiency in blood donors. Hematology 2010; 15:122-124
98. Shanthala DA, Helen R, Vanamala A, et al.: Screening for G6PD deficiency in blood donor population. Indian J Hematol Blood Transfus 2010; 26:122-123
99. Martuzzi VF, Stangoni A, Cuccuru GB, et al.: Glucose-6-phosphate dehydrogenase deficiency and blood groups in northern Sardinia. Hum Hered 1985; 35:399-402
100. Al-Nood HA, Bazara FA, Al-Absi R, et al.: Glucose-6-phosphate dehydrogenase deficiency among male blood donors in Sana'a city, Yemen. Oman Med J 2012; 27:46-49
101. Ahmed MA, al-Ali AK, al-Idrissi HY, et al.: Sickle cell trait and G6PD deficiency in blood donors in eastern Saudi Arabia. Vox Sang 1991; 61:69-70
102. Samilchuk E, Al-Suliman I, Usanga E, et al.: Glucose-6-phosphate dehydrogenase (G6PD) mutations and UDP-glucuronosyltransferase promoter polymorphism among G6PD deficient Kuwaitis. Blood Cells Mol Dis 2003; 31:201-205
103. Howes RE, Battle KE, Satyagraha AW, et al.: G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol 2013; 81:133-201
104. Pamba A, Richardson ND, Carter N, et al.: Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood 2012; 120:4123-4133
105. Calabro V, Cascone A, Malaspina P, et al.: Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A (-) associated with favism. Haematologica 1989; 74:71-73
106. Stainsby D, Dhingra N, James V, et al.:. Blood Donor Selection: Guidelines on Assessing Donor Suitability for Blood Donation. World Health Organization. Geneva, Switzerland, 2012
107. American Association of Blood Banks (AABB): Standards for blood banks and transfusion services. 28th edn. Bethesda, MA, AABB Press, 2012
108. Department of Health: Blood safety and quality regulations 2005. UK, Department of Health, 2005
109. Rosse WF, Gallagher D, Kinney TR, et al.: Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990; 76:1431-1437
110. Whitaker B, Schlumpf K, Schulman J, et al.: Report of the US department of health and human services. The 2009 National Blood Collection and Utilization Survey Report Office of the Assistant Secretary for Health. Washington, DC, US Department of Health and Human Services, 2011
111. Olowe SA, Ransome-Kuti O: Exchange transfusion using G-6-PD deficient or Hgb-AS blood in icteric neonates. J Natl Med Assoc 1981; 73:811-819
112. Gulati S, Singh S, Narang A, et al.: Exchange transfusion with G-6-PD deficient donor blood causes exaggeration of neonatal hyperbilirubinemia. Indian Pediatr 1989; 26:499-501
113. Nabavizadeh SH, Anushiravani A: The prevalence of G6PD deficiency in blood transfusion recipients. Hematology 2007; 12:85-88